These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G. J Clin Pharmacol; 1999 May; 39(5):454-61. PubMed ID: 10234592 [Abstract] [Full Text] [Related]
3. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group. Skinner R, Cotterill SJ, Stevens MC. Br J Cancer; 2000 May; 82(10):1636-45. PubMed ID: 10817497 [Abstract] [Full Text] [Related]
6. Growth impairment after ifosfamide-induced nephrotoxicity in children. Stöhr W, Patzer L, Paulides M, Kremers A, Beck JD, Langer T, Rossi R. Pediatr Blood Cancer; 2007 May; 48(5):571-6. PubMed ID: 16755549 [Abstract] [Full Text] [Related]
7. Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor. Raney B, Ensign LG, Foreman J, Khan F, Newton W, Ortega J, Ragab A, Wharam M, Wiener E, Maurer H. Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):286-95. PubMed ID: 7978043 [Abstract] [Full Text] [Related]
13. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, Langer T, Beck JD. Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552 [Abstract] [Full Text] [Related]
14. Renal function outcome in pediatric liver transplant recipients. Mention K, Lahoche-Manucci A, Bonnevalle M, Pruvot FR, Declerck N, Foulard M, Gottrand F. Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794 [Abstract] [Full Text] [Related]
16. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J. Bone Marrow Transplant; 2001 Feb; 27(3):319-27. PubMed ID: 11277181 [Abstract] [Full Text] [Related]
17. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations. Canpolat C, Pearson P, Robertson R, Jaffe N. Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510 [Abstract] [Full Text] [Related]
18. The influence of age on nephrotoxicity following chemotherapy in children. Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. Br J Cancer Suppl; 1992 Aug; 18():S30-5. PubMed ID: 1503924 [Abstract] [Full Text] [Related]